| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Albuterol (as albuterol sulfate) 100 microgram/actuation pressurized suspension for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Albuterol (as albuterol sulfate) 100 microgram/actuation pressurized suspension for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
2 |
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
2 |
| Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
2 |
| Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
2 |
| Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
2 |
| Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
2 |
| Cromolyn sodium 5 mg/actuation pressurized suspension for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Cromolyn sodium 5 mg/actuation pressurized suspension for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Terbutaline sulfate 500 microgram/actuation powder for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Terbutaline sulfate 500 microgram/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Beclometasone dipropionate 50 microgram/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Beclometasone dipropionate 50 microgram/actuation powder for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Budesonide 100 microgram/actuation powder for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Budesonide 100 microgram/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Budesonide 200 microgram/actuation powder for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Budesonide 200 microgram/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Indacaterol (as indacaterol maleate) 75 microgram/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Indacaterol (as indacaterol maleate) 75 microgram/actuation powder for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Ipratropium bromide 40 microgram/actuation powder for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Ipratropium bromide 40 microgram/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Indacaterol (as indacaterol maleate) 150 microgram/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Indacaterol (as indacaterol maleate) 150 microgram/actuation powder for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| budesonid 160 mikrogram/dos och formoterol 4,5 mikrogram/dos, inhalationspulver |
Has presentation strength denominator unit (attribute) |
False |
Actuation (unit of presentation) |
Inferred relationship |
Some |
2 |
| budesonid 160 mikrogram/dos och formoterol 4,5 mikrogram/dos, inhalationspulver |
Has unit of presentation |
False |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| budesonid 160 mikrogram/dos och formoterol 4,5 mikrogram/dos, inhalationspulver |
Has presentation strength denominator unit (attribute) |
False |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| budesonid 80 mikrogram/dos och formoterol 4,5 mikrogram/dos, inhalationspulver |
Has presentation strength denominator unit (attribute) |
False |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| budesonid 80 mikrogram/dos och formoterol 4,5 mikrogram/dos, inhalationspulver |
Has presentation strength denominator unit (attribute) |
False |
Actuation (unit of presentation) |
Inferred relationship |
Some |
2 |
| budesonid 80 mikrogram/dos och formoterol 4,5 mikrogram/dos, inhalationspulver |
Has unit of presentation |
False |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Sodium cromoglicate 800 microgram/actuation powder for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Sodium cromoglicate 800 microgram/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Sodium cromoglicate 5 mg/actuation powder for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Sodium cromoglicate 5 mg/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Salbutamol 400 microgram/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Salbutamol 400 microgram/actuation powder for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Sodium cromoglicate 20 mg/actuation powder for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Sodium cromoglicate 20 mg/actuation powder for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Budesonide 50 microgram/actuation nasal spray |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Budesonide 50 microgram/actuation nasal spray |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely desmopressin acetate 150 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely desmopressin acetate 150 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely sumatriptan 10 milligram/1 actuation conventional release nasal spray (clinical drug) |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely sumatriptan 10 milligram/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely sumatriptan 20 milligram/1 actuation conventional release nasal spray (clinical drug) |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely sumatriptan 20 milligram/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely triamcinolone acetonide 50 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely triamcinolone acetonide 50 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely zolmitriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely zolmitriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Beclometasone dipropionate 84 microgram/actuation nasal spray |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Beclometasone dipropionate 84 microgram/actuation nasal spray |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely ketorolac trometamol 15.8 milligram/1 actuation conventional release nasal spray (clinical drug) |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely ketorolac trometamol 15.8 milligram/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Ciclesonide 50 microgram/actuation nasal spray |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Ciclesonide 50 microgram/actuation nasal spray |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Lidocaine 10 mg/actuation oromucosal spray |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Lidocaine 10 mg/actuation oromucosal spray |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Olopatadine hydrochloride 665 microgram/actuation nasal spray |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Olopatadine hydrochloride 665 microgram/actuation nasal spray |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Budesonide 200 microgram/actuation solution for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Budesonide 200 microgram/actuation solution for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Cyanocobalamin 500 microgram/actuation nasal spray |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Cyanocobalamin 500 microgram/actuation nasal spray |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely budesonide 32 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely budesonide 32 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Salbutamol (as salbutamol sulfate) 2.5 mg/actuation solution for inhalation |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Salbutamol (as salbutamol sulfate) 2.5 mg/actuation solution for inhalation |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely fenoterol 500 microgram and ipratropium 1.25 milligram/1 actuation conventional release solution for inhalation (clinical drug) |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely fenoterol 500 microgram and ipratropium 1.25 milligram/1 actuation conventional release solution for inhalation (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely fenoterol 500 microgram and ipratropium 1.25 milligram/1 actuation conventional release solution for inhalation (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely dihydroergotamine mesilate 500 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely dihydroergotamine mesilate 500 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely sumatriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely sumatriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Ipratropium bromide 42 microgram/actuation nasal spray |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Ipratropium bromide 42 microgram/actuation nasal spray |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
| Prednisolone (as prednisolone metasulfobenzoate sodium) 20 mg/actuation rectal foam |
Has unit of presentation |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
|
| Prednisolone (as prednisolone metasulfobenzoate sodium) 20 mg/actuation rectal foam |
Has presentation strength denominator unit (attribute) |
True |
Actuation (unit of presentation) |
Inferred relationship |
Some |
1 |
FHIR